483
Indivior, Inc.Indivior, Inc. – FDA 483, Oct 19, 2017
Record Details
An FDA inspection of Indivior Inc. in Richmond, VA, revealed a failure to ensure proper monitoring of clinical study RB-US-13-0001. Specifically, the firm did not adhere to its Oversight Monitoring Plan, leading to issues with essential document review, monitoring visit report review, and final unblinded monitoring visits. These deficiencies resulted in inadequate drug accountability and reconciliation at study sites.
View Company Profile
ID · ef9dbf71-9783-4e50-bcd9-71a3826dafa7
Other documents for Indivior, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.